QUALITY BY DESIGN-GUIDED WHITE AND GREEN HPLC METHOD FOR THE DETERMINATION OF PROCESS-RELATED IMPURITIES OF ELACESTRANT IN BULK DRUG AND PHARMACEUTICAL FORMULATIONS
DOI:
https://doi.org/10.22159/ijap.2026v18i2.56991Keywords:
Elacestrant, Process-related impurities, Green analytical method, QbD approach, RGB profileAbstract
Objective: The quality by design (QbD) guided, robust, and environmentally sustainable HPLC method was developed for the simultaneous quantification of elacestrant and its process-related impurities.
Methods: The method optimisation uses organic solvent composition, mobile phase pH, and flow rate as critical method parameters. Based on structural features and pKa values of the analytes, separation was achieved on a hypersilgold C18 (250 × 4.6 mm, 5 µm) column using a green mobile phase of ethanol and 0.1% aqueous formic acid (65:35, v/v) at pH 3.4 at a 0.7 mL/min flow rate,achieving baseline resolution between elacestrant and its close eluting dihydrochloride impurity ( = 3.1) with good symmetry (tailing factor ~1.1) and a total run time of 13 min.
Results: The method validation demonstrates excellent linearity (r² > 0.999), accuracy (recoveries 99–101%), precision (RSD < 1.5%), and sensitivity (LOQs 0.1–0.2 µg/mL for impurities). The sustainability assessment confirms the strong environmental and operational profile of the method. The AGREE evaluation yields a score of 0.78, whereas the GAPI pictogram displays predominantly green fields,confirming the strong alignment of the proposed method with green analytical chemistry principles. Further, the RGB12 model demonstrates favourable scoresof 73.2% (redness), 75.8%(greenness), and 86.7% (blueness) with an integrated whiteness score of 78.3%. These results classify the proposed method as awhite analytical procedure.
Conclusion: Collectively, these outcomes confirm that the developed method was not only analytically reliable but also environmentally responsible and economically feasible. Hence, the method was highly suitable for routine impurity profiling and sustainable quality control of elacestrant in pharmaceutical formulations.
References
1. Valenza C, Trapani D, Bidard FC,Gligorov J,CortésJ, Turner N,Dalenc F,Penault-Llorca F, Freyer G, Arnedos M,Villanueva C,Loibl S,Pistilli B,Curigliano G.Elacestrant in ESR1-mutant, endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access. ESMO Journals. 2024;9(9):1-5. https://doi.org/10.1016/j.esmoop.2024.103701
2. Lloyd MR, Wander SA, Hamilton E, Razavi P, Bardia A. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role. Ther adv med oncol. 2022;14:https://doi.org/10.1177/17588359221113694
3. Teeru B, Hitisha K, Patel, Heike A,Nianjun T, Hai J, Jeffrey L, Brown, Dinesh M, Purandare, Gary H, Fiona G.Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models.Clin Cancer Res.2017;23(16):4793–4804. https://doi.org/10.1158/1078-0432.ccr-16-2561
4. Garner F, Shomali, Maysouna, Paquin, Dottie, Lyttle C, Richarda, Hattersley, Garya. RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. Anti-Cancer Drugs. 2015;26(9):948-956.https://doi.org/10.1097/cad.0000000000000271
5.Lakshmana Prabu S, Suriyaprakash TNK.impurities and its importance in pharmacy.International Journal of Pharmaceutical Sciences Review and Research.2010; 3(2);66-71.
6.ICH Guideline Q3C (R5) Guideline for Residual Solvents impurities; EMA/CHMP/ICH/82260/2006; 2011.
7. Bibhu Prasad Nanda, Priyanka Rani, Rohit Bhatia.Unexplored drug combinations for analytical method development by HPLC.Journal of Chromatography Open. 2024;5: 100123. https://doi.org/10.1016/j.jcoa.2024.100123
8. Ravinder B, Hemant KT, Vijay Srinivas P, Likhitha A, Sambasiva Rao T, Naveena G. analytical quality by design approach in RP-HPLC method development for the quantification of mirabegron and solifenacin succinate in pharmaceutical formulation. Letters in applied NanoBioScience.2024;14(1):1-12. https://doi.org/10.33263/LIANBS141.048
9.Jie W, Haozhe Y, Ning C, Jing Z, Jawad K, David L. Ecological footprint analysis as a tool for advancing sustainable development goals (SDGs): Evidence from China.Ecol Indic.2025;176:113653. https://doi.org/10.1016/j.ecolind.2025.113653
10.Amgoth KM, Tummala SR. LC-MS/MS approach for the quantification of five genotoxic nitrosoimpurities in varenicline. J Pharm Res. 2022;26(6):1685-1693. https://doi.org/10.29228/jrp.25
11. Prasad SS, Kasimala BB,Anna VR.QbD Based Analytical Method Development and Validation for the Separation and Quantification of Agomelatine and Its Impurities in Solid Oral Dosage Forms Using HPLC.RJC. 2021;14(4):2183-2190. http://doi.org/10.31788/RJC.2021.1446426
12. Sumant S, Ripandeep K, Ranjot K, Monica G, Bhupinder S, Afzal H, Abdul A, Mohhammad R, Mudassar S, Arusha A.QbD and green metric based HPLC method development and validation of bromocriptine mesylate in bulk product and biological samples.J Chromatogr B. 2025;1258;124566. https://doi.org/10.1016/j.jchromb.2025.124566
13. Subhashini K, Giri Prasad G, Rudraraju Ramesh R, Musunuri S. Quantitative Analysis of Elacestrantin Pharmaceutical Dosage Forms by Ultra-Performance Liquid Chromatography-Mass Spectrometry with Emphasis on Stability Assessment. Asian J Pharm Clin Res. 2025; 18(7):185–197. https://doi.org/10.22159/ajpcr.2025v18i7.54496
14. Sambasiva Rao Tummala, Krishnamanjari Pawar Amgoth.Development of GC-MS/MS method for simultaneous estimation of four nitrosoamine genotoxic impurities in valsartan.Turk J Pharm Sci. 2022, 19(4):455-461. https://doi.org/10.4274/tjps.galenos.2021.17702
15. Rajesh Varma B, Pavani P, Subhashini E, Kandula R, Bikshal Babu K. Green Analytical Approach for HPLC Method Development for Quantification of Sorafenib and Its Pharmacopeia Impurities: LC–MS/MS Characterization and Toxicity Prediction of Stress Degradation Products.Sep Sci Plus. 2024;https://doi.org/10.1002/sscp.202400106
16.Veerendraa YVS, Pradeep Kumar B, Sharad D,Mankumare,Jayaraju CH, Vinod K.Evaluation of analytical greenness metric for an eco-friendly method developed through the integration of green chemistry and quality-by-design for the simultaneous determination of Nebivolol hydrochloride, Telmisartan, Valsartan, and Amlodipine besylate.Heliyon.2024;10(16):e35376. https://doi.org/10.1016/j.heliyon.2024.e35376
17. Paweł Mateusz Nowak, Renata Wietecha-Posłuszny, Janusz Pawliszyn, White Analytical Chemistry: An approach to reconcile the principles of Green Analytical Chemistry and functionality, TrAC Trends in Analytical Chemistry, 2021; 138: 116223.https://doi.org/10.1016/j.trac.2021.116223
18. Charyulu KVS, ChandranRN, PatilSP, Jose J. Quality by Design (QBD) approach for optimization of mangiferin-loaded nanoparticles for the safe and effective treatment of breast cancer. International Journal of Applied Pharmaceutics, 2025;17(5): 146–158. https://doi.org/10.22159/ijap.2025v17i5.54215
19. Yalla K, Pawar AK, Manda K. A greenness evaluated bioanalytical method for quantification of sparsentan in rat plasma and its application to pharmacokinetic studies by LC-MS. International Journal of Applied Pharmaceutics, 2025;17(5): 168–180. https://doi.org/10.22159/ijap.2025v17i5.54341
Published
How to Cite
Issue
Section
Copyright (c) 2025 VENKATA SAI SURESH KUMAR SISTA, ANJALI JHA, VLNSH HARI HARAN A
This work is licensed under a Creative Commons Attribution 4.0 International License.
